These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK, Wilson IA. Science; 1999 Feb 12; 283(5404):987-90. PubMed ID: 9974392 [Abstract] [Full Text] [Related]
12. Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway. Wei S, Luo C, Yu S, Gao J, Liu C, Wei Z, Zhang Z, Wei L, Yi B. Exp Cell Res; 2017 Dec 15; 361(2):342-352. PubMed ID: 29102603 [Abstract] [Full Text] [Related]
15. Cbl negatively regulates erythropoietin-induced growth and survival signaling through the proteasomal degradation of Src kinase. Shintani T, Ohara-Waki F, Kitanaka A, Tanaka T, Kubota Y. Blood Cells Mol Dis; 2014 Dec 15; 53(4):211-8. PubMed ID: 25084697 [Abstract] [Full Text] [Related]
16. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation. Arcasoy MO, Harris KW, Forget BG. Exp Hematol; 1999 Jan 15; 27(1):63-74. PubMed ID: 9923445 [Abstract] [Full Text] [Related]
18. Polycythaemia-inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor-EPOR chimeras. Gross M, Ben-Califa N, McMullin MF, Percy MJ, Bento C, Cario H, Minkov M, Neumann D. Br J Haematol; 2014 May 15; 165(4):519-28. PubMed ID: 24533580 [Abstract] [Full Text] [Related]